Our Mission

Established in 2013, the Oklahoma Clinical and Translational Science Institute serves as a catalyst for clinical and translational research that improves health and healthcare for Oklahomans, to provide training and infrastructure to help junior investigators to launch independent research careers, and to expand the opportunities of IDeA states and Oklahoma communities to participate in research that improves the health of our residents. 

Oklahoma Shared Clinical and Translational Resources

OSCTR is Oklahoma's NIH-funded IDeA-CTR that provides resources, information, and training to help individuals or communities involved in performing clinical and translational research in the state

Oklahoma Primary Healthcare Improvement Cooperative

 

OPHIC is the implementation science arm of a statewide network to help improve healthcare delivery assisting primary care practices to adopt evidence-based best practices for the care of their patients.

OCTSI Clinical Research Unit

​​

The OCTSI CRU assists medical providers to identify and conduct clinical research opportunities in Oklahoma.

​

Oklahoma Health Services Research Conference Registration Now Open!

On behalf of the OCTSI and the Department of Medicine, we are pleased to announce the inaugural Oklahoma Health Services Research Conference! This event will showcase national leaders in health services research from outside institutions and across the University of Oklahoma Health Campus. This event is open to all faculty and trainees from all Colleges!

EVENT DATE: Tuesday, October 27, 2026, from 7:30 am to 4:30 pm 

2026 Oklahoma Conference for Statistics, Biostatistics and Data Science

The 2026 Oklahoma Conference for Statistics, Biostatistics and Data Science is coming soon!

Location: Hudson College of Public Health Building, Room 150 (801 NE 13th Street, Oklahoma City, OK 73104)

Conference Date: October 26-27, 2026

Contact Person(s): Chao Xu chao-xu@ouhsc.edu

Registration Deadline: October 20, 2026

Registration Cost:

Subscribe to News

Recent Publications

Increasing Multimorbidity Burden After COVID-19 Infection Among People With and Without HIV in the United States: Insights From the National Clinical Cohort Collaborative (N3C)

Open Forum Infect Dis. 2026 Sep 18;13(9):ofag560. doi: 10.1093/ofid/ofag560. eCollection 2026 Sep.

ABSTRACT

BACKGROUND: People with HIV (PWH) have a disproportionately high burden of chronic comorbidities. However, how their multimorbidity patterns differ from those of the general population and how COVID-19 infection may affect this burden have not been well characterized.

American Radium Society (ARS) Appropriate Use Criteria (AUC) for Low-Dose Radiotherapy for Treatment of Osteoarthritis

Am J Clin Oncol. 2026 May 25. doi: 10.1097/COC.0000000000001333. Online ahead of print.

ABSTRACT

OBJECTIVES: To summarize current evidence for radiotherapy in the treatment of OA. The population, intervention, comparator, and outcome questions included: What is the role of LDRT for treatment of OA?; What are risks of LDRT?; and What are the optimal RT techniques for OA?

Media